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Endocrine Cell Dysplasia (Nesidioblastosis): A Relatively
Unrecognized Entity in Pakistan?
Nasim Sabir,Irshad Nabi Soomro,Zafar Nazir,Abdul Jabbar,Sheema H. Hasan ( Department of Pathology, The Aga Khan
University Hospital, Karachi. ) 
Introduction 
Nesidioblastosis is quantitative as well as qualitative abnormality of pancreatic endocrine cells. There
is scattering of small endocrine cell clusters arranged haphazardly rather than the peripheral location
within the lobule1,2. Islet contours are irregular, tailing off into parenchyma3. These islets are present in
intimate association with ducts forming ductuloinsular complexes1 We recently encountered a new
born baby with signs and symptoms of endocrine cell dysplasia.
Case Report 
A baby boy was born to a mother who had lost two of her previous babies in early infancy. This
premature boy was born after Cesarean section and was large for gestational age having a birth weight
of 5.4 kg. A day after the birth he presented in the neonatal ICU with symptoms of lethargy and
grunting. On examination this boy was cyanosed and tachypnoeic. All the other reflexes appeared
normal. The laboratory investigations revealed his blood sugar to be 37 mg/dl and insulin level 26
iu/ml.
His condition improved after Intravenous infusion of 13% dextrose water but further 1-2 hourly blood
sugar assays reflected persistently low blood sugar levels. A single seizure also occurred on that night.
Breast feeding was initiated but still multiple doses of intravenous dextrose water were required to keep
the blood sugar levels normal. Other medications were also given, which initially comprised of
Intravenous injection of Hydrocortisone 10 mg six hourly and later injections Glucagon and
Somatostatin were also started regularly and as the condition did not improve much, Diazoxide was
also added to the previous treatment.
Irrespective of these measures For a period of one and a half—month the blood sugar levels remained
very low. mostly in the range of 20-80 mg!dl. The patient was eventually subjected to surgery on
October 10th 1998 and 90-95% of the pancreas was removed and sent for histopathology. The paraffin
embedded sect ions examined revealed a quantitative increase of endocrine cells. These were scattered
within pancreatic lobules haphazard ly, having irregular shapes and sizes, Endocrine nature of these
cells was further confirmed by panendoerine markers i.e.. Synaptophysin and Chromogranin.
Peroxidase antiperoxidase technique was used for antigen and antibody reaction. Specilic markers i.e.,
antibodies for insulin and glucagon are not available in our laboratory. The condition was diagnosed to
be benign hyperplasia of beta cells Islets of Laiigerhans, consistent with the features of
Nesidioblastosis,
Post-operatively the blood sugar levels gradually came back to normal and the patient was discharged.
He has been doing well since then and the last Follow up 6 months after being discharged revealed
normal blood glucose and insulin levels.
Discussion 
Nesidioblastosis, a state of persistent hyperinsulinemic hypoglycemia of infancy is actually’ a Greek
term nesidio (islet) and blastosis (proliferation)4,5 This disease must be considered as a medical
emergency. Prompt diagnosis and aggressive treatment can only save the life ola neonate, otherwise
permanent brain damage can result due to severe hypoglycemia. There can be other diseases resulting
in hypoglycemia. but Nesidioblastosis is the only one, which must be treated with surgical resection of
Pancrease3.
Clinically. Nesidioblastosis usually manifests within 48 hours of birth, with an instability of blood
glucose levels, usually’ occurring every hour or less after feeding. Other milder forms do occur, which
may he seen in the first six months of life. Signs of central nervous system glucopenia dominate the
clinical picture. Symptoms may be nonspecific like cyanosis, lethargy, hypotonia, hypothermia, poor
feeding, high pitched cry, irritability and convulsions, Other signs like irritability’ after long fasts,
confusion, bizarre behavior, headache, hunger abdominal pain and nausea can occur Signs of excessive
cateeholaniine release like tremors, pallor tachyeardia and coldsweats are usually observed in old
children. Though the symptoms may be nonspecific. persistent hypoglycemia should be documented
and treated with glucose.
Two highly significant findings have also been observed in the infants born with this disorder. Firstly
they are large for gestational age at birth and the weight goes on increasing due to high carbohydrate
feeding. Secondly they show no progressive hepatomegaly.
In Nesidioblastosis two histopathological forms have been discussed. focal and diffuse both occur at
equal frequcncy6 Focal lesions range from solitary adenorines to nodular hvperplasia ol islet cell
clusters. Which include ductuloinsular complexes and hyperirophic insular cells with giant nuclei7.
These lesions may be unifocal, multifocal or diffuse. In the diffuse type budding of endocrine cells
from pancreatic ducts, ductuloinsular complex. increased total endocrine areas and abnormalities in the
distribution of A,B,C.D and PP endocrine pancreatic cells arc shown to be present8.
Some researchers attribute both focal and diffuse type to increase in the nuclear size and DNA content
of the b cell9, which reflect metabolic hyperfunction b cells as a result of basic functional effect.
Another group using long term islet cell cultures on an extracellular matrix, demonstrated maximurn
insulin in secretion in the complete absence of glucose and attributed a defect in the control of insulin
secretion to be responsible for this hyperinsulinism.
The protocol For the diagnosis of this disease suggests that nesidioblastosis should be suspected when
the glucose requirement to avoid hypoglycemia is more than 15 mg/kg/minute. Multiple blood samples
for insulin (three to six) must be obtained at the time of hypoglycemia, as an appropriate insulin level
in a single sample does not exclude Ncsidioblastosis.
Other tests like measurement of free fatty acids, ketone bodies, urinary or plasma C-peptide may be
especially helpful in the diagnosis. Glucagon stimulation lest must be done to exclude hepatic or
metabolic defect. Imaging techniques like ultrasonography and computed tomography (CT) so far have
not been able to detect most of these localized lesions. Percutaneous transhepatic portal and pancreatic
vein catheterization with serial insulin measurement have been under investigation in children.
The treatment includes symptomatic measures such as intravenous glucose and dietary interventions,
attempts at suppression of insulin (with diazoxide or with long acting somatostatin analog Octreotide).
attempts at induction ol resistance to insulin effect with glucocorticoids or glucagon and reduction of
insulin secreting cells mass with specific cytotoxic drugs, or surgery. The surgical treatment of
hyperinsu lin ism in infancy and childhood is distal extensive (90-95%) sual pancreatectomy10.
The death of two previous siblings with almost similar symptoms, raises a suspicion of
hyperinsulinemic hypoglycemia, although this condition could not be documented, In both these infants
one could blame the ignorance of treating physician and raise a possibility of saving lives if proper
diagnosis was done and prompt treatment was initiated. Though this baby was saved due to prompt
diagnosis and efficient and timely management by the paediatric and the surgical team, still awareness
about this rare disorder in most primary and secondary care hospitals does not exist.
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